MedTrace Logo

Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation

NCT02385526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2018-07-23

Study results available
· View outcomes & findings →

Summary

Post-market, on-label, double-blind, randomized, prospective, interventional, tolerability and clinical outcomes study to determine the number of patients achieving their final assigned VNS Therapy dose settings in patients with drug-resistant epilepsy who are being treated with adjunctive VNS Therapy using new titration protocols.

Conditions

Interventions

DEVICE

Vagus Nerve Stimulation Therapy

Stimulation of the left tenth cranial nerve via VNS Therapy

Sponsors & Collaborators

  • Cyberonics, Inc.

    lead INDUSTRY

Principal Investigators

  • Jeff Way · Cyberonics, Inc.

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-28
Primary Completion
2016-10-10
Completion
2016-10-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02385526 on ClinicalTrials.gov